Please assess the completion status of the following clinical trial:

Trial Title: The Analgesic Effect of Combined Nerve Block and Systemic High Dose Glucocorticoid After Total Knee Arthroplasty.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age\> 50 years~* Patients set to cemented Total knee arthroplasty in spinal block~* ASA 1-3~Exclusion Criteria:~* Patients who can not cooperate with the investigation~* Patients who have given written informed consent to participate in the study after having understood the contents of the protocol and limitations fully~* Patients who do not understand or speak Danish~* Patients receiving immunosuppressive therapy~* Patients receiving glucocorticoid daily~* Patients with a treatment-dependent diabetes mellitus~* Patients with known neuropathy in the lower limbs~* Allergy to those used in the study drugs~* Alcohol and / or drug abuse - the investigator's opinion~* Patients who can not tolerate NSAIDs~* Fixed several times daily consumption of strong opioids (morphine, ketogan, Oxynorm, methadone, fentanyl)

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Combined nerve block (Type: EXPERIMENTAL): Ropivacaine and Adrenalin, systemic Ketorolac and high dose Dexamethasone
- Local infiltrationanalgesia (Type: ACTIVE_COMPARATOR): Ropivacaine, Adrenalin and Ketorolac combined with systemic high dose dexamethasone

Based on this trial design, predict the completion outcome and termination type (if applicable).